XML 34 R20.htm IDEA: XBRL DOCUMENT v3.22.0.1
Marketable Debt and Equity Securities (Tables)
12 Months Ended
Dec. 31, 2021
Marketable Debt and Equity Securities  
Schedule of marketable securities

December 31, 2021

Gross

Gross

    

Amortized

    

Unrealized

Unrealized

    

Cost

Gains

Losses

Fair Value

(in thousands)

Money Market Funds

$

123,892

$

$

$

123,892

Corporate Securities

144,584

(166)

144,418

Government Securities

311,148

1

(1,335)

309,814

$

579,624

$

1

$

(1,501)

$

578,124

Reported as

Cash and cash equivalents

$

123,892

Marketable securities

454,232

Total investments

$

578,124

December 31, 2020

Gross

Gross

    

Amortized

    

Unrealized

Unrealized

    

Cost

Gains

Losses

Fair Value

(in thousands)

Money Market Funds

$

158,937

$

$

$

158,937

Corporate Securities

119,782

57

(6)

119,833

Government Securities

315,319

37

(3)

315,353

$

594,038

$

94

$

(9)

$

594,123

Reported as

Cash and cash equivalents

$

158,937

Marketable securities

435,186

Total investments

$

594,123

Schedule of maturities of marketable securities

Amortized

    

Estimated

Cost

Fair Value

(in thousands)

Mature in one year or less

$

153,871

$

153,767

Mature within two years

301,861

300,465

$

455,732

$

454,232

Schedule of unrealized losses on available-for-sale investments

December 31, 2021

Less than 12 months

12 months or greater

Fair value

Unrealized losses

Fair value

Unrealized losses

(in thousands)

Corporate Securities

$

50,337

$

(51)

$

45,872

$

(115)

Government Securities

39,909

(54)

254,593

(1,281)

$

90,246

$

(105)

$

300,465

$

(1,396)

December 31, 2020

Less than 12 months

12 months or greater

Fair value

Unrealized losses

Fair value

Unrealized losses

(in thousands)

Corporate Securities

$

15,843

$

(6)

$

$

Government Securities

40,802

(3)

$

56,645

$

(9)

$

$

Schedule of equity securities with readily determinable fair value

The Company’s equity securities include securities with a readily determinable fair value. These investments are carried at fair value with changes in fair value recognized each period and reported within other income (expense). Equity securities with a readily determinable fair value and their fair values (in thousands) as of December 31, 2021 and 2020 are as follows:

Fair Value

    

Fair Value

December 31, 2021

December 31, 2020

Astria Common Stock

$

3,449

$

INmune Common Stock

19,233

Viridian Common Stock

14,178

5,303

$

36,860

$

5,303

Schedule of equity securities without readily determinable fair value

Carrying Value

    

Carrying Value

December 31, 2021

December 31, 2020

Astria Preferred Stock

$

312

$

Zenas Preferred Stock

30,950

16,071

$

31,262

$

16,071

Schedule of net gains and losses

Year Ended December 31, 

2021

2020

Net gains recognized on equity securities

$

39,289

$

105

Less: net gains recognized on equity securities redeemed

18,301

 

801

Unrealized gain (losses) recognized on equity securities

$

20,988

$

(696)